10 febrero 2017

PM01183 . Fase III Lung se lleva a cabo en 83 Hospitales de 16 Paises .

Resultado de imagen de pm01183 lungSponsor : 

PharmaMar .


Current Study:

ClinicalTrials.gov Identifier: NCT02566993 .



Study Title:

Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin (DOX) Versus Cyclophosphamide (CTX), Doxorubicin (DOX) and Vincristine (VCR) (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer (ATLANTIS).

First Received: September 24, 2015 .

Last Updated: February 8, 2017 .


Estimated Enrollment: 600
Study Start Date: July 2016
Estimated Primary Completion Date: June 2019 (Final data collection date for primary outcome measure) ,
Locations
United States, Alabama
Alabama Oncology
Birmingham, Alabama, United States, 35243
Principal Investigator: Kevin S. Windsor, MD         
United States, Arizona
Ironwood Physicians P.C. dba Ironwood Cancer & Research Centers
Chandler, Arizona, United States, 85224
Principal Investigator: Sujith Kalmadi, MD         
United States, California
St Jude Hospital Yorba Linda dba St Joseph Heritage Healthcare
Fullerton, California, United States, 92835
Principal Investigator: William Lawler, MD         
Innovative Clinical Research Institute (ICRI)
Whittier, California, United States, 90603
Principal Investigator: Daniel Huang, MD         
United States, Florida
Boca Raton Regional Hospital Lynn Cancer Institute
Boca Raton, Florida, United States, 33486
Principal Investigator: Edgardo Santos, MD         
Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center
Fort Lauderdale, Florida, United States, 33308
Principal Investigator: David Z. Drew, MD         
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, United States, 33612
Principal Investigator: Alberto Chiappori, MD         
United States, Illinois
Joliet Oncology-Hematology Associates, Ltd.
Joliet, Illinois, United States, 604
Principal Investigator: Jason Jung-Gon Suh, MD         
Healthcare Research Network III, LLC
Tinley Park, Illinois, United States, 60487
Principal Investigator: Subramanya S. Rao, MD         
United States, Kentucky
Norton Cancer Institute
Louisville, Kentucky, United States, 40202
Principal Investigator: John T. Hamm, MD         
Montgomery Cancer Center
Mount Sterling, Kentucky, United States, 40353
Principal Investigator: Muhammad-Ali Zaydan, MD         
United States, Maryland
Anne Arundel Medical Center Oncology and Hematology
Annapolis, Maryland, United States, 21401
Principal Investigator: Peter Graze, MD         
United States, Michigan
QUEST Research Institute
Royal Oak, Michigan, United States, 48073
Principal Investigator: Padmaja Vani Venuturumilli, MD         
United States, New Jersey
Carol G Simon Cancer Center
Morristown, New Jersey, United States, 07962
Principal Investigator: Sarada Gurubhagavatula, MD         
United States, North Carolina
FirstHealth Outpatient Cancer Center
Pinehurst, North Carolina, United States, 28374
Principal Investigator: Charles S. Kuzma, MD         
United States, Ohio
Gabrail Cancer Center Research
Canton, Ohio, United States, 44718
Principal Investigator: Nashat Y Gabrail, MD         
United States, Oklahoma
Oklahoma Cancer Specialists and Research Institute, LLC
Tulsa, Oklahoma, United States, 74146
Principal Investigator: Steven C. Buck, DO         
United States, Pennsylvania
Associates in Hematology and Oncology, P.C.
Upland, Pennsylvania, United States, 19013
Principal Investigator: Raymond J. Vivacqua, MD         
United States, Texas
Tyler Hematology-Oncology PA
Tyler, Texas, United States, 75701
Principal Investigator: Arielle S. Lee, MD         
United States, Washington
Medical Oncology Associates PS (dba Summit Cancer Centers)
Spokane, Washington, United States, 99208
Principal Investigator: Arvind Chaudhry, MD, PhD         
MultiCare Institute for Research & Innovation
Tacoma, Washington, United States, 98405
Principal Investigator: Michael A. Harris, MD         
United States, Wisconsin
Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin, United States, 53226
Principal Investigator: Smitha P. Menon, MD         
Austria
Universitätsklinik für Innere Medizin III der PMU
Salzburg, Austria, 5020
Principal Investigator: Richard Franz Greil, Univ Prof Dr         
Belgium
AZ Maria Middelares
Gent, Belgium, 9000
Principal Investigator: Paul Germonpré, MD         
Clinique André Renard
Herstal, Belgium, 4040
Principal Investigator: Léon Lionel Bosquee, MD         
CHR de la citadelle
Liege, Belgium, 4000
Principal Investigator: Frédérique Bustin, MD         
CHU de Liege - Sart Tilman
Liege, Belgium, 4000
Principal Investigator: Maryam Bourhaba, MD         
CHU Ambroise Paré
Mons, Belgium, 7000
Principal Investigator: Stéphane Holbrechts, MD         
Brazil
Nucleo de Oncologia da Bahia
Salvador, BA, Brazil, 40170-110
Principal Investigator: Clarissa Maria de Cerqueira Mathias, MD         
lOP- Instituto de oncologia do paraná
Curitiba, Paraná, Brazil, 80530-010
Principal Investigator: Fabricio A. Martinelli de Oliveira, MD         
Associação Hospital de Caridade de Ijuí
Ijui, RS, Brazil, 98700-000
Principal Investigator: Fabio A. Franke, MD         
Hospital São Lucas da PUCRS
Porto Alegre, RS, Brazil, 90610-000
Principal Investigator: Carlos H. Escosteguy Barrios, MD         
Fundação PlO XII - Hospital de Câncer de Barretos
Barretos, São Paulo, Brazil, 14784-400
Principal Investigator: Josiane Mourão Dias, MD         
lnstituto de Ensino e Pesquisa Säo Lucas - IEP Säo Lucas
Sao Paulo, São Paulo, Brazil, 01236-030
Principal Investigator: Lucas Vleira dos Santos, MD         
Bulgaria
Multiprofile Hospital for Active Treatment - Uni Hospital, Panagyurishte
Panagyurishte, Bulgaria, 4500
Principal Investigator: Rossitza Krasteva, MD         
Multiprofile Hospital for Active Treatment of Women Health - "Nadezhda", Sofia; Clinic of Medical Oncology
Sofia, Bulgaria, 1330
Principal Investigator: Constanta Timcheva, Prof         
University Multiprofile Hospital for Active Treatment "Sv. Ivan Rilski", Sofia
Sofia, Bulgaria, 1431
Principal Investigator: Bozhil Robev, MD         
Canada, Ontario
Southlake Regional Health Centre - Stronach Regional Cancer Centre
Newmarket, Ontario, Canada, L3Y 2P9
Principal Investigator: Amira Rana, MD         
R.S. Mc Laughlin Durham Regional Cancer Centre, Lakeridge Health
Oshawa, Ontario, Canada, L1G 2B9
Principal Investigator: Gregory Lo, MD         
Canada, Quebec
Centre intégré de santé et de services sociaux de la Montérégie Centre
Greenfield Park, Quebec, Canada, J4V 2H1
Principal Investigator: Giovanna Speranza, MD         
Recherche GCP Research
Montreal, Quebec, Canada, H1M 1B1
Principal Investigator: Michael Palumbo, MD         
Czech Republic
Vitkovicka nemocnice, a.s., Plicni oddeleni
Ostrava, Czech Republic, 703 84
Principal Investigator: Jaromir Roubec, MD         
Krajska zdravotni a.s. Masarykova nemocnice o.z.
Usti nad Labem, Czech Republic, 401 13
Principal Investigator: Pavel Reiterer, MD         
Germany
St. Vincentius-Kliniken, Karlsruhe
Karlsruhe, Germany, 76137
Principal Investigator: Jörg Mezger, Prof. Dr. med.         
Onkologische Schwerpunktpraxis Leer-Emden
Leer, Germany, 26789
Principal Investigator: Lothar Müller, Dr. med.         
Medizinische Klinik I
Wuppertal, Germany, 42283
Principal Investigator: Oliver Schmalz, Dr. med.         
Greece
General Hospital of Chest Diseases of Athens "Sotiria"
Athens, Greece, 11527
Principal Investigator: Konstantinos Syrigos, Prof         
General Oncology Hospital of Kifissia "Agioi Anargiroi", 2nd Internal Medicine-Oncology Clinic
Athens, Greece, 14564
Principal Investigator: Gerasimos Aravantinos, Dr         
General Hospital of Thessaloniki "G. Papanikolaou", Pulmonary Clinic, Aristotle University of Thessaloniki
Thessaloniki, Greece, 57010
Principal Investigator: Konstantinos Zarogoulidis, Prof         
Hungary
Országos Korányi TBC és Pulmonológiai Intézet, 6. Pulmonológia és Bronchologia
Budapest, Hungary, 1121
Principal Investigator: Andrea Fülöp, Dr         
Országos Korányi TBC és Pulmonológiai lntézet, 14. Pulmonológia
Budapest, Hungary, 1121
Principal Investigator: Ildikó Horváth, Dr         
Veszprém Megyei Tüdögyógyintézet, 3. Pulmonológiai Osztály
Farkasgyepu, Hungary, 8582
Principal Investigator: Balázs Medgyasszay, Dr         
Mátrai Gyógyintézet, Bronchológia
Matrahaza, Hungary, 3233
Principal Investigator: István Albert, Dr         
Miskolci Semmelweis Kórház és Egyetemi Oktatókórház, Pulmonológiai Osztály
Miskolc, Hungary, 3529
Principal Investigator: Eszter Csanky, Dr         
Fejér Megyei Szent György Egyetemi Oktató Kórház, I. Pulmonológiai Osztály
Szekesfehervar, Hungary, 8000
Principal Investigator: Zsolt Pápai-Székely, Dr         
Markusovszky Egyetemi Oktatókórház, Pulmonológiai Osztály
Szombathely, Hungary, 9700
Principal Investigator: Barna Szima, Dr         
Szent Borbála Kórház, Pulmonológiai osztály
Tatabanya, Hungary, 2800
Principal Investigator: Csaba Böcskei, PhD         
Zala Megyei Kórház, Pulmonologia
Zalaegerszeg, Hungary, 8900
Principal Investigator: Tehenes Sandor, Dr.         
Italy
Azienda Ospedaliero - Universitaria "Policlinico - Vittorio Emanuele" - Presidio G. Rodolico
Catania, Italy, 95123
Principal Investigator: Hector Soto Parra, MD         
Lebanon
Hotel Dieu de France
Achrafieh, Beirut, Lebanon
Principal Investigator: Joseph Kattan, Dr         
Ain Wazein Hospital
`Ain Wzei, El Chouf, Lebanon
Principal Investigator: Jawad Makarem, Dr         
American University of Beirut Medical Center
Beirut, Lebanon
Principal Investigator: Arafat Tfayli, Dr         
Centre Hospitalier Universitaire Notre Dame de Secours
Jbeil, Lebanon
Principal Investigator: Paul Khoueiry, Dr         
Hammoud Hospital University Medical Center
Saida, Lebanon
Principal Investigator: Fadi Farhat, Dr         
Portugal
Hospital CUF Porto
Porto, Portugal, 4100-180
Principal Investigator: Barbara Parente, MD         
Instituto Português de Oncologia do Porto Francisco Gentil, EPE
Porto, Portugal, 4200-072
Principal Investigator: Marta Soares, MD         
Spain
Hospital Universitari Germans Trias i Pujol ICO
Badalona, Barcelona, Spain, 08916
Principal Investigator: Enric Carcereny Costa, Dr         
Corporació Sanitaria Parc Taulí-Hospital de Sabadell
Sabadell, Barcelona, Spain, 08208
Principal Investigator: Yolanda García García, Dr         
Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, Madrid, Spain, 28222
Principal Investigator: Mariano Provencio Pulla, Dr         
Hospital Universitari Vall d' Hebron
Barcelona, Spain,
Principal Investigator: Alejandro Navarro Mendivil, Dr         
Hospital Universitario Reina Sofia
Cordoba, Spain, 14004
Principal Investigator: Isidoro Carlos Barneto Aranda, Dr         
MD Anderson Cancer Center Madrid
Madrid, Spain, 28033
Principal Investigator: Pilar López Criado, Dr         
Hospital Universitario Ramón y Cajal
Madrid, Spain, 28034
Principal Investigator: María Eugenia Olmedo García, Dr         
Hospital Universitario Clínico San Carlos
Madrid, Spain, 28040
Principal Investigator: José Luis González Larriba, Dr         
Hospital Universitario Fundación Jiménez Díaz
Madrid, Spain, 28040
Principal Investigator: Manuel Dómine Gómez, Dr         
Hospital Universitario 12 de Octubre
Madrid, Spain, 28041
Principal Investigator: Luis Paz-Ares Rodríguez, Dr         
Hospital Regional Universitario de Malaga
Malaga, Spain, 29010
Principal Investigator: Vanesa Gutierrez Calderón, Dr         
Complejo hospitalario regional virgen rocío
Sevilla, Spain, 41013
Principal Investigator: Amparo Sánchez Gastaldo, Dr.         
Hospital General Universitario de Valencia
Valencia, Spain, 46014
Principal Investigator: Ana Blasco Cordellat, Dr         
Hospital Universitario La Fe de Valencia
Valencia, Spain, 46026
Principal Investigator: Oscar Juan Vidal, Dr         
Hospital Universitario Miguel Servet
Zaragoza, Spain, 50009
Principal Investigator: Angel Artal Cortés, Dr         
United Kingdom
University College London Hospitals NHS Foundation Trust
London, United Kingdom, NW1 2PG
Principal Investigator: Martin David Forster, Dr         
Sarah Cannon Research Institute UK
London, United Kingdom, W1G 6AD
Principal Investigator: Hendrik-Tobias Arkenau, Dr.         
Sponsors and Collaborators
PharmaMar